5613127 PHARMACOKINETICS AND PHARMACODYNAMICS OF AN INNOVATIVE ORAL FORMULATION OF DECITABINE AND TETRAHYDROURIDINE IN HEALTHY PEOPLE

5613127 PHARMACOKINETICS AND PHARMACODYNAMICS OF AN INNOVATIVE ORAL FORMULATION OF DECITABINE AND TETRAHYDROURIDINE IN HEALTHY PEOPLE

Bibliographic Details
Main Authors:	Y. Saunthararajah, P.G. Woost, U. Friedrich, W.H.O. Clausen, J.W. Jacobberger, H. Lau
Format:	Article
Language:	English
Published:	Wiley 2023-04-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000928244.12444.62

Similar Items

P524: PHARMACODYNAMICALLY DEFINED METRONOMIC DOSING OF DECITABINE AND VENETOCLAX IN ACUTE MYELOID LEUKEMIA
by: Kateryna Fedorov, et al.
Published: (2023-08-01)

A pharmacokinetic and pharmacodynamic drug interaction between rosuvastatin and valsartan in healthy subjects
by: Jung JA, et al.
Published: (2015-03-01)

Pharmacokinetics and pharmacodynamics of curcumin.
by: Sharma, R, et al.
Published: (2007)

Pharmacokinetic, Pharmacokinetic/Pharmacodynamic, and Safety Investigations of Lefamulin in Healthy Chinese Subjects
by: Yingying Hu, et al.
Published: (2023-08-01)

Application of Pharmacokinetic and Pharmacodynamic Analysis to the Development of Liposomal Formulations for Oncology
by: Sihem Ait-Oudhia, et al.
Published: (2014-03-01)

Population pharmacokinetic and pharmacodynamic modeling of evobrutinib in healthy adult participants
by: Orestis Papasouliotis, et al.
Published: (2022-12-01)

Pharmacokinetic and pharmacodynamic properties of orally administered torasemide in healthy cats
by: Marine Roche‐Catholy, et al.
Published: (2022-09-01)

Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine.
by: White, N, et al.
Published: (1999)

Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling to Predict the Impact of CYP2C9 Genetic Polymorphisms, Co-Medication and Formulation on the Pharmacokinetics and Pharmacodynamics of Flurbiprofen
by: Ioannis Loisios-Konstantinidis, et al.
Published: (2020-11-01)

Pharmacokinetic and Pharmacodynamic Characteristics of Pelubiprofen Tromethamine vs. Pelubiprofen in Healthy Subjects
by: Yu-Jeong Son, et al.
Published: (2023-04-01)

Influence of Probenecid on the Pharmacokinetics and Pharmacodynamics of Sorafenib
by: Koen G. A. M. Hussaarts, et al.
Published: (2020-08-01)

Pharmacokinetics, pharmacodynamics, and tolerability of verinurad, a selective uric acid reabsorption inhibitor, in healthy adult male subjects
by: Shen Z, et al.
Published: (2017-07-01)

Pharmacokinetic-pharmacodynamic modeling and simulation /
by: 192959 Bonate, Peter L.
Published: (2005)

Isavuconazole Pharmacokinetics and Pharmacodynamics in Children
by: Hirsh Elhence, et al.
Published: (2022-12-01)

The Pharmacokinetics and Pharmacodynamics of Iron Preparations
by: Susanna Burckhardt, et al.
Published: (2011-01-01)

A comparison of the pharmacokinetic and pharmacodynamic properties of quinine and quinidine in healthy Thai males.
by: Karbwang, J, et al.
Published: (1993)

Population Pharmacokinetic and Pharmacodynamic Modeling of Acetazolamide in Peritoneal Dialysis Patients and Healthy Volunteers
by: Corinne Seng Yue, et al.
Published: (2013-04-01)

Pharmacokinetics, pharmacodynamics, and safety of prandial oral insulin (N11005) in healthy subjects
by: Qi Pan, et al.
Published: (2023-07-01)

Effect of herbal formulation on glimepiride pharmacokinetics and pharmacodynamics in nicotinamide-streptozotocin-induced diabetic rats
by: Archana K. Thikekar, et al.
Published: (2022-07-01)

Pharmacokinetics and Pharmacodynamics of Esomezol DR, a New Dual Delayed-Release Formulation of Esomeprazole 20 Mg or 40 Mg, in Healthy Subjects
by: Kim HC, et al.
Published: (2023-04-01)

Comparison of the pharmacokinetic and pharmacodynamic properties of two recombinant granulocyte colony-stimulating factor formulations after single subcutaneous administration to healthy volunteers
by: Audrius Sveikata, et al.
Published: (2014-01-01)

Pharmacokinetic and pharmacodynamic assessment of co-amoxiclav in the treatment of melioidosis.
by: Chierakul, W, et al.
Published: (2006)

Pharmacokinetics and Pharmacodynamics of Colistin Methanesulfonate in Healthy Chinese Subjects after Multi-Dose Regimen
by: Yaxin Fan, et al.
Published: (2022-06-01)

Gatifloxacin Pharmacokinetics/Pharmacodynamics-based Optimal Dosing for Pulmonary and Meningeal Multidrug-resistant Tuberculosis
by: Deshpande, D, et al.
Published: (2018)

Clinical pharmacokinetics and pharmacodynamics of artemisinin and derivatives.
by: White, N
Published: (1994)

Clinical pharmacokinetics and pharmacodynamics of artemether-lumefantrine
by: White, N, et al.
Published: (1999)

Ketoprofen in the Cat: Pharmacodynamics and Chiral Pharmacokinetics
by: Lees, Peter, et al.
Published: (2003)

Proteasome Inhibitors and Their Pharmacokinetics, Pharmacodynamics, and Metabolism
by: Jinhai Wang, et al.
Published: (2021-10-01)

Insights into the Pharmacogenetics of Tacrolimus Pharmacokinetics and Pharmacodynamics
by: Mercè Brunet, et al.
Published: (2022-08-01)

The Overview on the Pharmacokinetic and Pharmacodynamic Interactions of Triazoles
by: Andrzej Czyrski, et al.
Published: (2021-11-01)

Pharmacokinetic and pharmacodynamic properties of pantoprazole in calves
by: Jeff D. Olivarez, et al.
Published: (2023-01-01)

Zopiclone: some remarks on pharmacokinetics and pharmacodynamics
by: Swiss Medical Weekly
Published: (2003-02-01)

Pharmacokinetic and pharmacodynamic responses in adult patients with Chagas disease treated with a new formulation of benznidazole
by: Marisa Liliana Fernández, et al.
Published: (2016-03-01)

Pharmacokinetic and pharmacodynamic assessments of atogepant in healthy male adults: Results from phase 1 studies
by: Ramesh Boinpally, et al.
Published: (2023-08-01)

Pharmacokinetic and pharmacodynamic drug–drug interactions between evogliptin and empagliflozin or dapagliflozin in healthy male volunteers
by: Dasohm Kim, et al.
Published: (2023-08-01)

Pharmacokinetics, pharmacodynamics, and safety of verinurad with and without allopurinol in healthy Asian, Chinese, and non‐Asian participants
by: Susanne Johansson, et al.
Published: (2022-06-01)

Pharmacokinetic Behavior and Pharmacokinetic/Pharmacodynamic Integration of Danofloxacin Following Single or Co-Administration with Meloxicam in Healthy Lambs and Lambs with Respiratory Infections
by: Mehmet Nihat Ural, et al.
Published: (2021-09-01)

Absence of early platelet increment in healthy mice during decitabine treatment
by: Juliane Baumann, et al.
Published: (2022-12-01)

Pharmacokinetic And Pharmacodynamic Modeling Of Mitragynine In PainTolerance
by: Ramachandram, Dinesh Sangarran
Published: (2020)

Pharmacokinetic and pharmacodynamic considerations in antimalarial dose optimization.
by: White, N
Published: (2013)